70 Biggest Movers From Friday

Gainers

  • InnSuites Hospitality Trust IHT shares gained 43.4% to close at $3.50 on Friday.
  • Velocity Financial, Inc. VEL rose 36.6% to close at $12.50 following Q1 earnings.
  • Yield10 Bioscience, Inc. YTEN jumped 26.2% to close at $10.83.
  • The L.S. Starrett Company SCX gained 26.2% to close at $7.85 after reporting higher quarterly earnings.
  • Orgenesis Inc. ORGS gained 24.4% to settle at $5.66 after the company swung to a Q1 profit.
  • Regional Health Properties, Inc. RHE rose 24.2% to close at $18.60 after dropping 23% on Thursday.
  • Core Molding Technologies, Inc. CMT surged 23.5% to close at $13.98 after the company reported higher Q1 earnings.
  • MoneyGram International, Inc. MGI gained 22.8% to settle at $8.03after the company reported better-than-expected Q1 sales results. The company issued Q2 sales guidance above analyst estimates.
  • Cooper-Standard Holdings Inc. CPS jumped 21.9% to close at $34.88 following strong quarterly sales.
  • Phio Pharmaceuticals Corp. PHIO gained 21.9% to settle at $2.67.
  • Epizyme, Inc. EPZM surged 21.7% to close at $8.29 after SVB Leerink upgraded the stock from Market Perform to Outperform and raised its price target from $12 to $16per share.
  • MEDNAX, Inc. MD gained 20% to close at $32.10 after the company reported better-than-expected Q1 results.
  • Funko, Inc. FNKO surged 19.9% to settle at $25.45 after the company reported better-than-expected Q1 results.
  • Y-mAbs Therapeutics, Inc. YMAB gained 19.3% to close at $34.20 after reporting a Q1 profit.
  • Bill.com Holdings, Inc. BILL climbed 18.3% to close at $154.23 after the company reported better-than-expected Q3 results and issued strong Q4 guidance.
  • LM Funding America, Inc. LMFA shares jumped 17.8% to close at $4.47. The company announced a 1-for-5 reverse stock split effective May 7.
  • Pro-Dex, Inc. PDEX jumped 17.3% to close at $34.37 after reporting a rise in quarterly earnings.
  • Golden Entertainment, Inc. GDEN gained 17.2% to close at $41.91 after the company reported better-than-expected Q1 sales results.
  • iBio, Inc. IBIO rose 16.7% to close at $1.61 after the company provided an update on its IBIO-201 program and reported on its progress in developing a second-generation subunit vaccine candidate, IBIO-202, being designed for the prevention of SARS-CoV-2 infection.
  • Auris Medical Holding Ltd. EARS surged 16.6% to settle at $3.3450 after the company issued an update on Bentrio program in allergy.
  • EMCORE Corporation EMKR rose 16.5% to settle at $7.28. The company, last week, reported better-than-expected Q2 EPS and sales results.
  • Recro Pharma, Inc. REPH gained 16.3% to settle at $2.92 following strong Q1 results.
  • BioVie Inc BIVI gained 16.3% to close at $15.35.
  • Atossa Therapeutics, Inc. ATOS rose 16.1% to settle at $2.74.
  • Qurate Retail, Inc. QRTEA jumped 15.9% to close at $13.70 following upbeat quarterly results.
  • BlueLinx Holdings Inc. BXC gained 15.8% to settle at $66.81.
  • Clene Inc. CLNN surged 15.3% to close at $9.19.
  • PubMatic, Inc. PUBM rose 14.9% to settle at $44.62.
  • Tilray, Inc. TLRY climbed 14.4% to close at $16.18 after Jefferies upgraded the stock from Underperform to Buy and raised its price target from $4.77 to $23 per share.
  • Assertio Holdings, Inc. ASRT shares gained 14.3% to settle at $0.57 after the company reported better-than-expected Q1 results.
  • CarGurus, Inc. CARG gained 13.6% to settle at $27.35 after the company reported better-than-expected Q1 EPS and sales results.
  • Nikola Corporation NKLA gained 13.4% to close at $11.50 after the cpmpany posted a narrower-than-expected quarterly loss.
  • ADTRAN, Inc. ADTN climbed 13.3% to settle at $19.93. The company recently released Q1 results.
  • The Manitowoc Company, Inc. MTW surged 12.4% to close at $27.26.
  • Roku, Inc. ROKU shares gained 11.6% to settle at $317.00 after the company reported better-than-expected Q1 results and issued strong Q2 revenue guidance.
  • Cyclerion Therapeutics, Inc. CYCN shares gained 10.8% to close at $2.76.
  • Tabula Rasa HealthCare, Inc. TRHC gained 10.5% to close at $47.13 after reporting Q1 results.
  • Avalon Holdings Corporation AWX rose 8.8% to close at $4.51.
  • Datadog, Inc. DDOG rose 8.3% to close at $77.29 after the company reported better-than-expected Q1 results and issued sales guidance above estimates.
  • Diana Shipping Inc. DSX gained 7% to settle at $3.98 after the company reported a time chart contract for m/v Myrsini with Bocimar.
  • CureVac N.V. CVAC rose 6.9% to settle at $100.40 after dropping over 7% on Thursday.
  • Expedia Group, Inc. EXPE rose 5.2% to close at $173.46 after the company reported better-than-expected Q1 results.

 

Check out these big penny stock gainers and losers

Losers

  • ChemoCentryx, Inc. CCXI shares tumbled 62% to close at $10.46 on Friday after the company said the FDA's Arthritis Advisory Committee that evaluated avacopan for the treatment of antineutrophil cytoplasmic autoantibody-associated vasculitis gave a split verdict on whether the efficacy data support approval of avacopan. The committee voted 9-7 in favor of safety and 10-8 that the benefit-risk profile is adequate to support approval of avacopan at the proposed dose of 30 mg twice daily.
  • Orphazyme A/S ORPH dipped 32.2% to settle at $5.75 after the company announced that the ORARIALS-01 pivotal trial of arimoclomol in amyotrophic lateral sclerosis (ALS) did not meet its primary and secondary endpoints.
  • Centerra Gold Inc. CGAU fell 29.8% to close at $6.92.
  • SIFCO Industries, Inc. SIF dropped 22.5% to settle at $9.90 after reporting a loss for the second quarter.
  • SemiLEDs Corporation LEDS fell 22.2% to close at $7.95.
  • Aemetis, Inc. AMTX dropped 21.3% to settle at $13.07.
  • F-star Therapeutics, Inc. FSTX fell 19.6% to settle at $7.13 after the company priced its 9.29 million shares common stock offering at $7 per share.
  • SunLink Health Systems, Inc. SSY dropped 19.4% to close at $3.45.
  • Waterdrop Inc. WDH fell 19.2% to close at $9.70 after the company priced its IPO at $12 per ADS.
  • Natural Grocers by Vitamin Cottage, Inc. NGVC dipped 18.8% to close at $12.95 after the company reported a decline in quarterly earnings.
  • Aurinia Pharmaceuticals Inc. AUPH fell 17.8% to close at $10.15 after the company reported a wider Q1 loss.
  • Drive Shack Inc. DS dropped 17.7% to settle at $2.80 after reporting a Q1 loss.
  • American Shared Hospital Services AMS shares declined 17.6% to close at $3.41.
  • Teradata Corporation TDC fell 16.3% to settle at $40.54 after the company issued weak FY21 earnings forecast.
  • MoSys, Inc. MOSY dropped 15.9% to close at $3.28 after the company issued Q2 sales guidance below analyst estimates.
  • ShiftPixy, Inc. PIXY shares fell 15.6% to close at $2.54 after jumping 25% on Thursday.
  • Shake Shack Inc. SHAK fell 15.3% to close at $89.48 after the company reported downbeat Q1 sales and issued weak Q2 sales guidance.
  • Travere Therapeutics, Inc. TVTX dropped 14.8% to close at $20.01 following weak quarterly results.
  • Precipio, Inc. PRPO fell 14.7% to settle at $3.84.
  • JFrog Ltd. FROG fell 14.6% to close at $35.91 after the company reported Q1 earnings results.
  • Home Point Capital Inc. HMPT dropped 14.5% to close at $6.60. Piper Sandler downgraded Home Point Capital from Overweight to Neutral and lowered the price target from $18 to $8.
  • Charles & Colvard, Ltd. CTHR fell 13.7% to close at $2.83 after the company reported Q3 earnings results.
  • Universal Electronics Inc. UEIC tumbled 13.6% to settle at $50.58 following weak quarterly sales.
  • Waitr Holdings Inc. WTRH dropped 12.4% to settle at $2.13 after the company reported worse-than-expected Q1 earnings.
  • Farmer Bros. Co. FARM fell 10.8% to close at $9.28 after the company reported worse-than-expected Q3 results.
  • Installed Building Products, Inc. IBP fell 7.5% to close at $127.57 after the company reported worse-than-expected Q1 results.
  • Stealth BioTherapeutics Corp MITO fell 6.2% to close at $1.52. Stealth BioTherapeutics shares jumped 35% on Thursday in reaction to new data from a post hoc analysis of Phase 1 ReCLAIM study evaluating elamipretide in patients with noncentral geographic atrophy (GA) and high-risk drusen associated with dry age-related macular degeneration (AMD).
  • Global Partners LP GLP shares fell 5% to close at $24.84 after the company reported worse-than-expected Q1 earnings.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasMovers From YesterdayTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!